Teratocarcinoma-Derived Growth Factor 1, Member 3 (TDGF1.3) Peptid
TDGF1.3
Reaktivität: Human, Maus
Wirt: Synthetic
BP, BI
-
- Target Alle Cripto-1 (TDGF1.3) Produkte
- Cripto-1 (TDGF1.3) (Teratocarcinoma-Derived Growth Factor 1, Member 3 (TDGF1.3))
- Spezies
- Human, Maus
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), BioImaging (BI)
- Produktmerkmale
- Cripto-1 peptide corresponds to 16 amino acids of Cripto-1.
-
-
- Applikationshinweise
- Cripto-1 Peptide is used for blocking the activity of Cripto-1 antibody . The Cripto-1 antibody ships at 0.5 mg/mL and the Cripto-1 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Cripto-1 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
-
Sie sind hier:
